Prot #BB2121-EAP-001: Expanded Access Protocol (EAP) for Subjects Receiving Idecabtagene Vicleucel That Is Nonconforming for Commercial Release

Project: Research project

Project Details

StatusActive
Effective start/end date12/8/20 → 1/30/26

Funding

  • DrugDev Inc. (Prot #BB2121-EAP-001 // Prot #BB2121-EAP-001)
  • Celgene Corporation (Prot #BB2121-EAP-001 // Prot #BB2121-EAP-001)